세포 및 유전자 조사 리뷰(2024년)

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

The global market for cell therapy biomanufacturing is expected to grow from $9.7 billion in 2024 and is projected to reach $16.7 billion by the end of 2029, at a CAGR of 11.5% during the forecast period of 2024 to 2029.

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a CAGR of 15.8% from 2023 through 2028.

Research Review Scope:

Cell and gene therapy is a vast industry that uses cells and genes in research, development, manufacture, and distribution to treat diseases. Cells and genes can be utilized in preclinical studies, clinical trials, the production of therapies, viral vectors, modified cells, and personalized medicine.

One of the major factors in this market's growth is the increasing investment and funding. The rapid growth in research and development of new cell and gene therapies, along with a new level of innovation, also fuels the growth of this market. However, the high cost of developing these therapies restrains the market's growth.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of Cell and Gene Therapy provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.

This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO208C Cell and Gene Therapy Tools, and Reagents: Global Markets.
• BIO211B Cell Therapy Biomanufacturing: Global Markets.
• BIO251A Gene Synthesis: Technologies and Global Markets.
• BIO258A Global Automated and Closed Cell Therapy Market.
• BIO225B Global Market for Cell and Gene Therapy.
• BIO256A Global Live Cell Imaging Market.
• BIO257A Global Single-cell Technologies Market.

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)

• Scope of Report of Cell and Gene Therapy Tools, and Reagents
• Market Summary of Cell and Gene Therapy Tools, and Reagents
• Market Overview of Cell and Gene Therapy Tools, and Reagents
• Approved CGT Products
• Market Dynamics of Cell and Gene Therapy Tools, and Reagents
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Segmentation Analysis of Cell and Gene Therapy Tools, and Reagents
• Segmentation Breakdown of Cell and Gene Therapy Tools, and Reagents
• Global Market for CGT Tools and Reagents, by Product
• Immunoassays
• Bioreactors
• Leukapheresis
• GMP Antibodies
• Multiplex Immunoassays
• Vectors
• Cell Separation
• Cryopreservation
• Cell Expansion
• Media
• GMP Proteins
• GMP Small Molecules
• CRS Monitoring
• Global Market for CGT Tools and Reagents, by Application
• Cancer
• Rare Diseases
• Other Diseases
• Global Market for CGT Tools and Reagents, by End User
• Pharmaceutical and Biotech Companies
• Academic and Research Institutes
• Clinical Laboratories
• Geographic Breakdown
• Global Market for CGT Tools and Reagents, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Emerging Technologies and Developments of Cell and Gene Therapy Tools, and Reagents
• Closed and Automated Systems
• Single-Use Technologies
• Sustainability in the CGT Tool and Reagent Market: ESG Perspective
• Introduction to ESG
• ESG Performance in the Industry
• ESG Practices in the CGT Tool and Reagent Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 3 Cell Therapy Biomanufacturing: Global Markets (BIO211B)

• Scope of Report of Cell Therapy Biomanufacturing
• Market Summary of Cell Therapy Biomanufacturing
• Market Overview of Cell Therapy Biomanufacturing
• Overview
• Market Dynamics of Cell Therapy Biomanufacturing
• Overview
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Segmentation Analysis of Cell Therapy Biomanufacturing
• Key Market Trends
• Cell Therapy Biomanufacturing: Global Markets
• Segmentation Breakdown of Cell Therapy Biomanufacturing
• Market Analysis of Cell Therapy Biomanufacturing, by Product Type
• Market Analysis of Cell Therapy Biomanufacturing, by Application
• Skeletal Muscle Repair
• Bone Repair
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Other Diseases
• Geographic Breakdown of Cell Therapy Biomanufacturing
• Market Analysis of Cell Therapy Biomanufacturing, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 4 Gene Synthesis: Technologies and Global Markets (BIO251A)

• Scope of Report of Gene Synthesis
• Market Summary of Gene Synthesis
• Market Overview of Gene Synthesis
• Overview of Gene Synthesis
• Market Dynamics of Gene Synthesis
• Overview
• Market Drivers
• Restraints
• Opportunities
• Challenges
• Segmentation Breakdown of Gene Synthesis
• Gene Synthesis: Global Market
• Global Market for Gene Synthesis, by Method
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis
• Global Market for Gene Synthesis, by Services
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Other Gene Synthesis Services
• Gene Synthesis: Global Markets, by Application
• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Other Applications
• Global Market for Gene Synthesis, by End User
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Geographic Breakdown of Gene Synthesis
• In-house or Outsource?
• Cost Considerations
• Quality Control and Assurance
• Convenience and Turnaround Time
• Customization and Specialization
• Strategic Considerations
• M&A and Venture Funding of Gene Synthesis
• In Summation

Chapter 5 Global Automated and Closed Cell Therapy Market (BIO258A)

• Scope of Report of Automated and Closed Cell Therapy
• Market Insights of Automated and Closed Cell Therapy
• Market Overview of Automated and Closed Cell Therapy
• Overview
• Market Dynamics of Automated and Closed Cell Therapy
• Market Drivers
• Market Restraints
• Market Opportunities
• Segmentation Breakdown of Automated and Closed Cell Therapy
• Global Automated and Closed Cell Therapy Market by Automation Type
• Semi-Automated Cell Therapy
• Fully Automated Cell Therapy
• Global Automated and Closed Cell Therapy Market by Cell Type
• CAR-T Cells
• Stem Cells
• Other Cell Types
• Global Automated and Closed Cell Therapy Market by Application
• Market Size and Forecast
• Clinical
• Commercial
• Geographic Breakdown of Automated and Closed Cell Therapy
• Global Market for Automated and Closed Cell Therapy by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 6 Global Market for Cell and Gene Therapy (BIO225B)

• Scope of Report of Cell and Gene Therapy
• Market Summary of Cell and Gene Therapy
• Market Value of Cell and Gene Therapy
• Market Overview of Cell and Gene Therapy
• Cell and Gene Therapy Overview
• Market Dynamics of Cell and Gene Therapy
• Market Drivers
• Market Restraints
• Market Opportunities
• Segmentation Breakdown of Cell and Gene Therapy
• Global Market for Cell and Gene Therapy
• Market Analysis
• Cell Therapy
• Market Size and Forecast
• Gene-modified Cell Therapy
• Market Size and Forecast
• Gene Therapy
• Market Forecast
• Vectors Used in Gene-modified Cell Therapy and Gene Therapy
• Market Analysis
• Adeno-Associated Viral Vectors
• Retroviral Vectors
• Lentiviral Vectors
• Other Vectors Used in Gene Therapy
• Market Breakdown by Drug Product
• Zolgensma
• Yescarta
• Kymriah
• Abecma
• Maci
• Tecartus
• Epicel
• Other Drug Products
• Market Breakdown by Application
• Oncology
• Rare Diseases
• Ophthalmology
• Other Therapeutic Areas
• Geographic Breakdown of Cell and Gene Therapy
• Market Breakdown of Cell and Gene Therapy by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Global Live Cell Imaging Market (BIO256A)

• Scope of Report of Live Cell Imaging
• Market Summary of Live Cell Imaging
• Market Overview of Live Cell Imaging
• Overview
• Market Dynamics of Live Cell Imaging
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Segmentation Breakdown of Live Cell Imaging
• Market Segmentation of Live Cell Imaging by Components
• Instruments and Software
• Consumables
• Services
• Market Segmentation of Live Cell Imaging, by Technology
• Time-Lapse Microscopy
• Fluorescence Resonance Energy Transfer (FRET)
• Fluorescence Recovery After Photobleaching (FRAP)
• High-Content Screening (HCS)
• Other Technologies
• Market Segmentation of Live Cell Imaging by End User
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Geographic Breakdown of Live Cell Imaging
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 8 Global Single-cell Technologies Market (BIO257A)

• Scope of Report of Single-cell Technologies
• Market Summary of Single-cell Technologies
• Market Overview of Single-cell Technologies
• Market Dynamics of Single-cell Technologies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Segmentation Breakdown of Single-cell Technologies
• Market Analysis of Single-cell Technologies by Product
• Consumables
• Instruments
• Market Breakdown of Single-cell Technologies by Cell Type
• Human Cells
• Animal Cells
• Microbial Cells
• Market Breakdown by Technique
• Flow Cytometry
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microscopy
• Mass Spectrometry
• Other Techniques
• Market Breakdown of Single-cell Technologies by Application
• Research Applications
• Medical Applications
• Market Breakdown of Single-cell Technologies by End User
• Research and Academic Laboratories
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Laboratories
• Cell Banks and IVF Centers
• Geographic Breakdown of Single-cell Technologies
• Market Analysis by Region of Single-cell Technologies
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 9 Appendix

• Methodology
• Analyst's Credentials